Investing-News.Com
Information for Investors

PEREGRINE PHARMA, (PPHM) Stock Ratings - Investing-News.Com
 

 Home   Market News   Analysis   Commentary   Education   Tools   Weekly Report 

Internet Search   Stock Search
   

 

PEREGRINE PHARMA, (PPHM) Stock Rating Learn More

Our Overall Rating on Peregrine Pharmaceuticals,  PPHM is BUY
StockPickReport.Com research suggests PPHM's price will move significantly higher than the "open price" the day this rating was initiated.

This analysis is based on short-term stochastic and "relative strength" indicators.

Both stochastic and "relative strength" indicators point to a move up.

Investors, traders, and other market participants may find this a good opportunity to buy PPHM, "buy calls", or "sell puts".

This may also be an opportunity to raise targets and stop/losses to allow for potential gains.

Trading volume seems to be falling and PPHM's closing price moved up during the week before this rating was initiated.

Our BUY Rating on PPHM was issued on 03/25/08

PEREGRINE PHARMA Technical Rating



Ratings Provided by Stock-Letter-Daily.Com

Rate Any Stock
(enter symbol and click)

Stock Rating Definitions

Stock Ratings Home

Sponsored Links:

Software Forces PEREGRINE PHARMA Investors To Buy Low and Sell High The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in PEREGRINE PHARMA buy low and sell high every time guaranteed. Click Here To Learn More

We Give Precision Entry & Exit Points on PEREGRINE PHARMA. This software is specially designed to give precision entry and exit points on PEREGRINE PHARMA, or any other stock you choose.
Click Here to learn how to take control of your trading.

How To Know When PEREGRINE PHARMA Beats The Street. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even PEREGRINE PHARMA, if they make the cut.
Click Here & Learn To
Pick Winners In An Uncertain Market



Related Searches: stock market ticker  day trading stocks  options grant timing  sun capital cello-foil 

Research Home


Article Search


Advanced Search

StreetInsider Alerts

Latest Headlines

Avid Bioservices Expands Capabilities With Installation of Innovative Thermo Scientific HyClone Single-Use Bioreactor Systems (PR Newswire)

Peregrine Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Healthcare Conference (PR Newswire)

Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008 (PR Newswire)

Avid Bioservices to Serve as Contract Manufacturer for Catalyst Biosciences' Novel Human Coagulation Factor Clinical Candidate (PR Newswire)

PEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule (EDGAR Online)

Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer (PR Newswire)

Peregrine Pharmaceuticals Completes Patient Enrollment In First Stage of Bavituximab Phase II Lung Cancer Trial (PR Newswire)

Peregrine Pharmaceuticals' anti-PS Technology Platform to Be Discussed at AIDS Vaccine 2008 Conference (PR Newswire)

Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial (PR Newswire)

PEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule (EDGAR Online)

  Place Our Content On Your Site!  rss Powered By The Investing System Network
© 2006 Investing-News.Com, All Rights Reserved.